Public
American Hospital Association content that is available to the public and all website users.
The AHA in collaboration with Health-ISAC and the field identified attempted and ongoing ransomware attacks potentially due to SimpleHelp remote monitoring and management (RMM) software vulnerabilities.
Recent reporting indicates that threat actors are exploiting patched vulnerabilities in SimpleHelp Remote Monitoring and Management (RMM) software to gain unauthorized access to private networks.
Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for patients in vulnerable communities.
Each year we review a slew of health care outlooks and, after sifting through them, here are a few of the more interesting hypotheses.
Laura J. Stone's latest offering in her three-volume series “A Pocket Guide to Purpose” provides a road map for driving team performance and efficiency.
January 27, 2025Jeff WuActing AdministratorCenters for Medicare & Medicaid Services7500 Security BlvdBaltimore, MD 21244Re: CMS 4208-P, Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program,…
In the first Leadership Dialogue of 2025, Tina Freese Decker, president and CEO of Corewell Health and 2025 AHA board chair, talks with two policy experts at the AHA — Stacey Hughes, executive vice president of government relations and public policy, and Ashley Thompson, senior vice president of…
The AHA strongly opposes site-neutral payment cuts, which would reduce access to critical health care services, especially in rural and other underserved communities.
n this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage, director of population health at Englewood Hospital, discuss what Englewood Health is doing to prevent opioid use in its communities.
A follow-up to Baxter’s communication on December 13, 2024 regarding increases in allocations for several U.S. IV products,